Corporate-Backed Trade Deal Would Directly Hurt Poor Americans
The Korea-U.S. "free" trade deal is proceeding apace, and Big Pharma is pleased. But do state lawmakers, healthcare providers and low-income patients know what's being negotiated on their behalf?